SCHEMBL15475876

SCHEMBL15475876

CN(CCN(C)c1ccnc2cc(Cl)ccc12)CCN(C)c1ccnc2cc(Cl)ccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHKA P35790 1/20 0.58
FERMT2 Q96AC1 1/20 0.50
NR4A2 P43354 4/20 0.47
SOS2 Q07890 1/20 0.47
LMNA P02545 2/20 0.47
KDM4E B2RXH2 1/20 0.47
HTT P42858 1/20 0.47
HSD17B10 Q99714 1/20 0.47
CYP1A2 P05177 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
KCNH2 Q12809 2/20 0.44
CCR1 P32246 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
PRNP P04156 1/20 0.44
APP P05067 1/20 0.44
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44
CHRM5 P08912 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6388962 0.87 CHKA (0.57) CHKAFERMT2NR4A2SOS2LMNA
SCHEMBL14708808 0.82 CHKA (0.52) CHKAFERMT2NR4A2SOS2LMNA
SCHEMBL3454549 0.82 KCNH2 (0.60) CHKAFERMT2NR4A2LMNAKDM4E
SCHEMBL14698794 0.81 CHKA (0.51) CHKAFERMT2NR4A2SOS2LMNA
Hydrochloric Acid SCHEMBL15476175 0.81 CHKA (0.51) CHKAFERMT2NR4A2SOS2LMNA
SCHEMBL30058586 0.81 CHKA (0.68) CHKAFERMT2NR4A2SOS2LMNA
SCHEMBL1706258 0.81 CHKA (0.68) CHKAFERMT2NR4A2SOS2LMNA
SCHEMBL18281201 0.80 FERMT2 (0.54) CHKAFERMT2NR4A2SOS2LMNA
SCHEMBL17834978 0.80 CHKA (0.50) CHKAFERMT2NR4A2SOS2LMNA
SCHEMBL18281263 0.79 CHKA (0.54) CHKAFERMT2NR4A2SOS2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140050696-A1 NOVEL BISAMINOQUINOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS PREPARED THEREFROM AND THEIR USE THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2014-02-20 US claimed
US-20170166530-A1 NOVEL BISAMINOQUINOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS PREPARED THEREFROM AND THEIR USE THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2017-06-15 US disclosed
US-20160168099-A1 NOVEL BISAMINOQUINOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS PREPARED THEREFROM AND THEIR USE THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2016-06-16 US disclosed
US-20160168099-A1 NOVEL BISAMINOQUINOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS PREPARED THEREFROM AND THEIR USE THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2016-06-16 US disclosed
US-20140050696-A1 NOVEL BISAMINOQUINOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS PREPARED THEREFROM AND THEIR USE THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2014-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160168099-A1 NOVEL BISAMINOQUINOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS PREPARED THEREFROM AND THEIR USE UACA, SQSTM1, ATG7 CHKA 906/4885FERMT2 4433/4885NR4A2 4610/4885
US-20140050696-A1 NOVEL BISAMINOQUINOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS PREPARED THEREFROM AND THEIR USE UACA, SQSTM1, ATG7 CHKA 906/4885FERMT2 4433/4885NR4A2 4610/4885
US-20170166530-A1 NOVEL BISAMINOQUINOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS PREPARED THEREFROM AND THEIR USE UACA, SQSTM1, ATG7 CHKA 906/4885FERMT2 4433/4885NR4A2 4610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.